Analyst consensus rating
Intensity Therapeutics, Inc. Analyst Consensus Rating
INTS analyst consensus rating, coverage count and price target evidence.
Direct answer
Intensity Therapeutics, Inc.'s consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $24.80.
Forecast evidence checked August 13, 2026.
Get free Intensity Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.16
- Average price target
- $24.80
- High price target
- $32.00
- Low price target
- $12.00
- Target upside
- +496.2%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026